Observational Study
Copyright ©The Author(s) 2020.
World J Radiol. Aug 28, 2020; 12(8): 184-194
Published online Aug 28, 2020. doi: 10.4329/wjr.v12.i8.184
Table 1 Demographics and characteristics of cohort
GroupGout (n = 31)Control (n = 18)
Age, median (min-max) (n)63 (31-86) (31)49 (26-73) (18)
Male Gender (n, %)26 (83.9)6 (33.3)
History of CAD (n, %)9 (29.0)2 (11.1)
Diabetes (n, %)15 (48.4)4 (22.2)
Ever Smoked (n, %)19/29 (65.5)0/11 (0.0)
Total Cholesterol, median (min-max) (n)165 (114-250) (25)192 (145-247) (11)
HDL, median (min-max) (n)43 (24-88) (25)61 (35-88) (11)
LDL, median (min-max) (n)99 (58-179.2) (25)110 (66-139) (11)
Hemoglobin A1C, median (min-max) (n)5.9 (5.0-10.5) (24)5.7 (5.2-11) (9)
Systolic BP, median (min-max) (n)138 (98-175) (29)126.5 (101-157) (12)
Diastolic BP, median (min-max) (n)80 (61-104) (29)79.5 (66-99) (12)
Serum urate, median (min-max) (n)6 1-13.5) (29)4.4 (3.2-4.5) (3)
Total MSU volume aorta, mm3 median (min-max) (n)43.9 (0-1113.5) (31)2.9 (0-219.4) (18)
MSU spots Aorta median (min-max) (n)20(0-739) (31)1.5(0-104) (18)
Table 2 Comparison of tophaceous vs non tophaceous gout groups
GroupTophaceous goutNon tophaceous gout
Age, median (min-max) (n)64 (33-86) (16)60 (31-77) (15)
Male gender (n, %)14 (87.5)12 (80.0)
History of CAD (n, %)4 (25.0)5 (33.3)
Diabetes (n, %)7 (43.8)8 (53.3)
Ever smoked (n, %)8 (50.0)11 (73.3)
Total cholesterol, median (min-max) (n)162 (114-250) (12)176 (128-234) (13)
HDL, median (min-max) (n)40 (24-61) (12)52 (26-88) (13)
LDL, median (min-max) (n)92.5 (61.6-179.2) (12)103.4 (58-143) (13)
Hemoglobin A1C, median (min-max) (n)6 (5.5-10.5) (12)5.5 (5-6.4) (12)
Systolic BP, median (min-max) (n)136 (98-175) (15)140 (120-156) (14)
Diastolic BP, median (min-max) (n)80 (64-104) (15)82 (61-101) (14)
Serum Urate, median (min-max) (n)6.7 (1-13.5) (16)5.6 (2.9-12.7) (13)
Total MSU volume aorta, mm3 median (min-max) (n)38 (0-1113.5) (16)43.9 (0-374.2) (15)
MSU spots aorta median (min-max) (n)24.5(0-739) (16)20(0-157) (15)